Episodic Src activation in uveal melanoma revealed by kinase activity profiling

por Maat, W, Filali, M el, Mulder, A Dirks-, Luyten, G P M, Gruis, N A, Desjardins, L, Boender, P, Jager, M J, van der Velden, P A
Publicado 2009

Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS

por Zuidervaart, W, van Nieuwpoort, F, Stark, M, Dijkman, R, Packer, L, Borgstein, A-M, Pavey, S, van der Velden, P, Out, C, Jager, M J, Hayward, N K, Gruis, N A
Publicado 2005

Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development

por Zuidervaart, W, van der Velden, P A, Hurks, M H, van Nieuwpoort, F A, Out-Luiting, C J J, Singh, A D, Frants, R R, Jager, M J, Gruis, N A
Publicado 2003

GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi

por Vader, M J C, Madigan, M C, Versluis, M, Suleiman, H M, Gezgin, G, Gruis, N A, Out-Luiting, J J, Bergman, W, Verdijk, R M, Jager, M J, van der Velden, P A
Publicado 2017

Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study

por Demenais, F., Mohamdi, H., Chaudru, V., Goldstein, A. M., Newton Bishop, J. A., Bishop, D. T., Kanetsky, P. A., Hayward, N. K., Gillanders, E., Elder, D. E., Avril, M. F., Azizi, E., van Belle, P., Bergman, W., Bianchi-Scarrà, G., Bressac-de Paillerets, B., Calista, D., Carrera, C., Hansson, J., Harland, M., Hogg, D., Höiom, V., Holland, E. A., Ingvar, C., Landi, M. T., Lang, J. M., Mackie, R. M., Mann, G. J., Ming, M. E., Njauw, C. J., Olsson, H., Palmer, J., Pastorino, L., Puig, S., Randerson-Moor, J., Stark, M., Tsao, H., Tucker, M. A., van der Velden, P., Yang, X. R., Gruis, N.
Publicado 2010